A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an anti-PD-1 Monoclonal Antibody, in Patients with Advanced Solid Tumors

2023-506390-35-00 Protocol 4010-01-001 Human pharmacology (Phase I) - First administration to humans Ongoing, recruitment ended

Start 19 Apr 2017 · Status Ongoing, recruitment ended · 6 EU/EEA countries · 42 sites · Protocol 4010-01-001

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - First administration to humans
Status Ongoing, recruitment ended
Participants planned 945
Countries 6
Sites 42

Patients with Advanced Solid Tumors

Key facts

Sponsor
Tesaro Inc.
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Neoplasms [C04]
Trial duration
19 Apr 2017 → ongoing
Decision date (initial)
2024-03-18
Transition trial
Yes
Low-intervention
No
Rare-disease indication
No
Vulnerable population
Yes

External identifiers

EU CT number
2023-506390-35-00
EudraCT number
2016-000320-26
ClinicalTrials.gov
NCT02715284

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Patients with Advanced Solid Tumors

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Tesaro Inc.

Sponsor organisation
Tesaro Inc.
Address
1000 Winter Street Suite 3300
City
Waltham
Postcode
02451-1230
Country
United States

Scientific contact point

Organisation
Tesaro Inc.
Contact name
Tesaro, Inc

Public contact point

Organisation
Tesaro Inc.
Contact name
Tesaro, Inc

Locations

6 EU/EEA countries · 42 investigational sites

By country

CountryMS statusPlanned subjectsSites
Czechia Ongoing, recruitment ended 5 1
Denmark Ongoing, recruitment ended 7 1
France Ongoing, recruitment ended 129 9
Italy Ongoing, recruitment ended 55 5
Poland Ongoing, recruitment ended 130 4
Spain Ongoing, recruitment ended 194 22
Rest of world
Argentina, Mexico, United States, Brazil, Korea, Republic of, United Kingdom, Canada
425

Investigational sites

Czechia

1 site · Ongoing, recruitment ended
Krajska Nemocnice T Bati a.s.
Komplexní onkologické centrum (Comprehensive Oncology Center), Havlickovo Nabrezi 600, 760 01, Zlin

Denmark

1 site · Ongoing, recruitment ended
Rigshospitalet
Dept. of Oncology 5073, Blegdamsvej 9, 2100, Copenhagen Oe

France

9 sites · Ongoing, recruitment ended
Assistance Publique Hopitaux De Paris
Service d’Oncologie Médicale, 20 Rue Leblanc, 75015, Paris
Centre Francois Baclesse
Département de Médecine Oncologique, 3 Avenue Du General Harris, Cs 45026, Caen Cedex 5
Centre Oscar Lambret
Département de Cancérologie Gynécologie, 3 Rue Frederic Combemale, 59000, Lille
Hopital Saint Antoine
Service d’Oncologie médicale, 184 Rue Du Faubourg Saint Antoine, 75571, Paris Cedex 12
Centre Hospitalier Lyon Sud
Département d’Oncologie Médicale, 165 Chemin Du Grand Revoyet, 69310, Pierre-Benite
Institut Bergonie
Départment D'Oncologie Médicale, 180 R De Saint Genes, 229 Cours De L Argonne, Bordeaux
Institut Gustave Roussy
Département d’Innovation Thérapeutique et des Essais Précoses, 114 Rue Edouard Vaillant, 94800, Villejuif
Institut De Cancerologie De L Ouest
Service d'Oncologie Médicale, Boulevard Jacques Monod, 44805, Saint-Herblain Cedex
Institut Paoli Calmettes
Département d’Oncologie médicale, 232 Boulevard De Sainte Marguerite, Bp 156, Marseille

Italy

5 sites · Ongoing, recruitment ended
IRCCS Istituto Nazionale Tumori Fondazione Pascale
SC Sperimentazioni Cliniche, Via Mariano Semmola 52, 80131, Naples
Azienda Ospedaliero Universitaria Di Modena
Struttura complessa di Oncologia, Largo Del Pozzo 71, 41124, Modena
European Institute Of Oncology S.r.l.
Divisione di Sviluppo di Nuovi Farmaci per Terapie Innovative, Via Giuseppe Ripamonti 435, 20141, Milan
Ospedale San Raffaele S.r.l.
Dipartimento di Oncologia Medica Settore Q - 1° piano, Via Olgettina 60, 20132, Milan
Fondazione IRCCS Istituto Nazionale Dei Tumori
Oncologia Medica, Via Giacomo Venezian 1, 20133, Milan

Poland

4 sites · Ongoing, recruitment ended
Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy
Oddział Badań Wczesnych Faz, Ul. Wilhelma Konrada Roentgena 5, 02-781, Warsaw
Szpitale Pomorskie Sp. z o.o.
Oddział Onkologii i Radioterapii, Ul. Powstania Styczniowego 1, 81-519, Gdynia
Olsztynski Osrodek Onkologiczny Kopernik Sp. z o.o.
Chemotherapy Clinic, Ul. Mikolaja Kopernika 30, 10-513, Olsztyn
Wojewodzki Szpital Zespolony Im.L.Rydygiera W Toruniu
Oddział Chemioterapii Nowotworów, Ul. Sw. Jozefa 53/59, 87-100, Torun

Spain

22 sites · Ongoing, recruitment ended
Hospital De La Santa Creu I Sant Pau
Medical Oncology Department, Carrer De San Quinti 89, 08041, Barcelona
Hospital Universitario La Paz
Oncology Service Department, Paseo Castellana 261, 28046, Madrid
Hospital Universitario Virgen De La Victoria
Medical Oncology Department, Calle Del Arroyo Teatinos Sn, 29010, Malaga
Institut Catala D'oncologia
Oncology Department, Avinguda De La Gran Via De L'hospitalet 199-203, 08908, L'hospitalet De Llobregat
Hospital General Universitario Reina Sofia
Oncology Department, Avenida Menendez Pidal S/n, 14004, Cordoba
Hospital Universitario Hm Sanchinarro
Oncology Department, Calle Ona 10, 28050, Madrid
Hospital Universitari Vall D Hebron
Oncology Department, Edificio Materno-Infantil, Passeig De La Vall D'hebron 119-129, Barcelona
Hospital Universitario Marques De Valdecilla
Oncology Department, Avenida Valdecilla Sn, 39008, Santander
Complexo Hospitalario Universitario De Santiago
Medical Oncology Department, Calle Choupana Da S/n, 15706, Santiago De Compostela
University Hospital Virgen Del Rocio S.L.
Oncology Department, Avenida De Manuel Siurot S/n, 41013, Sevilla
Hospital Clinic De Barcelona
Medical Oncology Department, Calle Villarroel 170, 08036, Barcelona
Fundacion Instituto Valenciano De Oncologia
Oncology Department, Calle Professor Beltran Baguena 8, 46009, Valencia
Clinica Universidad De Navarra
Oncology Department, Calle Marquesado De Santa Marta 1, 28027, Madrid
Hospital Universitario De Jaen
Medical Oncology Department, Avenida Del Ejercito Espanol 10, 23007, Jaen
Institut Catala D'oncologia
Oncology Service Department, Avinguda De Franca S/n, 17007, Girona
Hospital Clinico San Carlos
Oncology Department, Calle Del Profesor Martin Lagos Sn, 28040, Madrid
University Clinical Hospital Virgen De La Arrixaca
Oncology Department, Carretera De Cartagena Sn, El Palmar, Murcia
Clinica Universidad De Navarra
Oncology Department, Avenue Pio XII 36, 31008, Pamplona
Hospital Unviersitario Miguel Servet
Medical Oncology Department, Paseo De Isabel La Catolica 1-3, 50009, Zaragoza
Hospital Universitari Arnau De Vilanova De La Gerencia Territorial De Lleida
Oncology Department, Avinguda De L'alcalde Rovira Roure 80, 25196, Lleida
Hospital Clinico Universitario De Valencia
Oncology Service Department, Avenida Blasco Ibanez 17, 46010, Valencia
Hospital Universitario Fundacion Jimenez Diaz
Oncology Department, Avenida De Los Reyes Catolicos 2, 28040, Madrid

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Czechia 2017-06-28 2017-10-30 2025-05-09
Denmark 2017-05-30 2018-01-26 2025-05-09
France 2017-08-24 2017-11-23 2025-05-09
Italy 2017-07-04 2018-03-08 2025-05-09
Poland 2017-10-13 2018-03-26 2025-05-09
Spain 2017-04-19 2017-06-13 2025-05-09

Application history

7 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-02-12 Denmark Acceptable
2024-03-15
2024-03-18
2 SUBSTANTIAL MODIFICATION SM-1 2024-06-26 Acceptable 2024-09-02
3 SUBSTANTIAL MODIFICATION SM-2 2024-08-14 Acceptable 2024-10-21
4 SUBSTANTIAL MODIFICATION SM-3 2024-11-12 Denmark Acceptable
2025-02-25
2025-02-26
5 SUBSTANTIAL MODIFICATION SM-4 2025-11-28 Denmark Acceptable
2026-02-16
2026-02-16
6 SUBSTANTIAL MODIFICATION SM-5 2026-03-04 Acceptable 2026-03-16
7 SUBSTANTIAL MODIFICATION SM-6 2026-04-29 Acceptable 2026-05-29